TFS CAPITAL LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 138 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.

Quarter-by-quarter ownership
TFS CAPITAL LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$334,000
+136.9%
33,809
+107.6%
0.09%
+242.3%
Q2 2016$141,000
-18.5%
16,286
-11.1%
0.03%
+4.0%
Q1 2016$173,000
-54.8%
18,310
-35.8%
0.02%
-32.4%
Q3 2015$383,000
-81.9%
28,503
-80.8%
0.04%
-82.1%
Q1 2015$2,116,000
+1013.7%
148,179
+610.2%
0.21%
+1193.8%
Q3 2014$190,000
-53.4%
20,864
-23.4%
0.02%
-15.8%
Q4 2013$408,000
-74.8%
27,247
-81.4%
0.02%
-74.3%
Q3 2013$1,616,000
+32.5%
146,416
-4.6%
0.07%
+45.1%
Q2 2013$1,220,000153,4320.05%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$51,293,0007.24%
First Light Asset Management, LLC 2,050,273$93,103,0005.59%
TRAN CAPITAL MANAGEMENT, L.P. 1,350,870$61,343,0005.06%
SNYDER CAPITAL MANAGEMENT L P 3,176,404$144,241,0004.04%
DOHENY ASSET MANAGEMENT /CA 91,930$4,175,0002.69%
Redwood Investments, LLC 538,656$24,460,0001.97%
HighMark Wealth Management LLC 53,457$2,427,0001.78%
Taylor Wealth Management Partners 85,409$3,878,0001.37%
SILVERARC CAPITAL MANAGEMENT, LLC 66,673$3,028,0001.35%
Granite Investment Partners, LLC 919,029$41,733,0001.29%
View complete list of HALOZYME THERAPEUTICS INC shareholders